Abstract:Background and purpose: Increasing evidence suggests systemic inflammation-caused skeletal muscle atrophy as a major clinical feature of cachexia. Triptolide obtained from Tripterygium wilfordii Hook F possesses potent anti-inflammatory and immunosuppressive effects. The present study aims to evaluate the protective effects and molecular mechanisms of triptolide on inflammation-induced skeletal muscle atrophy. Experimental approach: The effects of triptolide on skeletal muscle atrophy were investigated in LPS-treated C2C12 myotubes and C57BL/6 mice. Protein expressions and mRNA levels were analysed by western blot and qPCR, respectively. Skeletal muscle mass, volume and strength were measured by histological analysis, micro-CT and grip strength, respectively. Locomotor activity was measured using the open field test. Key results: Triptolide (10-100 fM) up-regulated protein synthesis signals (IGF-1/p-IGF-1R/IRS-1/p-Akt/p-mTOR) and down-regulated protein degradation signal atrogin-1 in C2C12 myotubes. In LPS (100 ng·ml-1 )-treated C2C12 myotubes, triptolide up-regulated MyHC, IGF-1, p-IGF-1R, IRS-1 and p-Akt. Triptolide also down-regulated ubiquitin-proteasome molecules (n-FoxO3a/atrogin-1/MuRF1), proteasome activity, autophagy-lysosomal molecules (LC3-II/LC3-I and Bnip3) and inflammatory mediators (NF-κB, Cox-2, NLRP3, IL-1β and TNF-α). However, AG1024, an IGF-1R inhibitor, suppressed triptolide-mediated effects on MyHC, myotube diameter, MuRF1 and p62 in LPS-treated C2C12 myotubes. In LPS (1 mg·kg-1 , i.p.)-challenged mice, triptolide (5 and 20 μg·kg-1 ·day-1 , i.p.) decreased plasma TNF-α levels and it increased skeletal muscle volume, cross-sectional area of myofibers, weights of the gastrocnemius and tibialis anterior muscles, forelimb grip strength and locomotion. Conclusions and implications: These findings reveal that triptolide prevented LPS-induced inflammation and skeletal muscle atrophy and have implications for the discovery of novel agents for preventing muscle wasting.

Triptolide attenuate the oxidative stress induced by LPS/D-GalN in mice.

Triptolide attenuates oxidative stress, NF-kappaB activation and multiple cytokine gene expression in murine peritoneal macrophage.

A Study on Triptolide Protects Against Lipopolysaccharide- Induced Endotoxemia by Anti Inflammation Effect

Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways

Involvement of oxidative stress in the mechanism of triptolide-induced acute nephrotoxicity in rats

[Tripotolide Ameliorates Inflammation and Apoptosis Induced by Focal Cerebral Ischemia/reperfusion in Rats].

Proteasome activity inhibition mediates endoplasmic reticulum stress-apoptosis in triptolide/lipopolysaccharide-induced hepatotoxicity

Anti-inflammatory effects of triptolide by inhibiting the NF-κB signalling pathway in LPS-induced acute lung injury in a murine model.

Triptolide Protects Mice from Ischemia/reperfusion Injury by Inhibition of IL-17 Production.

Anti-inflammatory and neuroprotective effects of Triptolide via the NF-κB signaling pathway in a rat MCAO model.

Triptolide Induces Liver Injury by Regulating Macrophage Recruitment and Polarization Via the Nrf2 Signaling Pathway.

Triptolide induces oxidative damage in NRK-52E cells through facilitating Nrf2 degradation by ubiquitination via the GSK-3β/Fyn pathway

Comprehensive analysis of transcriptomics and metabolomics to understand triptolide-induced liver injury in mice

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis

The Protective Effects of Isoliquiritigenin and Glycyrrhetinic Acid Against Triptolide-Induced Oxidative Stress in HepG2 Cells Involve Nrf2 Activation.

A New Perspective of Triptolide-Associated Hepatotoxicity: Liver Hypersensitivity Upon LPS Stimulation.

Role of Nrf2 in protection against triptolide-induced toxicity in rat kidney cells

Triptolide-induced Oxidative Stress Involved with Nrf2 Contribute to Cardiomyocyte Apoptosis Through Mitochondrial Dependent Pathways.

Triptolide Attenuated Injury Via Inhibiting Oxidative Stress in Amyloid-Beta25–35-treated Differentiated PC12 Cells

Triptolide Attenuates Cerebral Ischemia and Reperfusion Injury in Rats Through the Inhibition the Nuclear Factor Kappa B Signaling Pathway

Triptolide prevents LPS-induced skeletal muscle atrophy via inhibiting NF-κB/TNF-α and regulating protein synthesis/degradation pathway